• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
    • Corporate Videos
  • Development Programs
    • Biopharmaceutical Trials
    • Group Strategy and Target Markets
    • NTI164
    • Clinical Trials
    • Pathways to Commercialisation
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Investor Conference Calls  
    • Company Reports
    • Presentations
    • Research
    • News & Media
    • Fact Sheets
    • Analyst Reports
    • Right to Receive Documents
  • Contact

Corporate Videos

  • Neurotech Corporate Video

    4 July 2023

    View More: Neurotech Corporate Video
  • Neurotech International 52 Week Phase I/II Autism Clinical Trial Data Presentation

    16 March 2023
    View More: Neurotech International 52 Week Phase I/II Autism Clinical Trial Data Presentation
  • Neurotech International South West Connect

    23 October 2022
    View More: Neurotech International South West Connect
  • New Hope for children living with Autism. Channel 7 NEWS 28 August 2022

    28 August 2022
    View More: New Hope for children living with Autism. Channel 7 NEWS 28 August 2022
  • Neurotech International (ASX:NTI) – Breakthrough results with NTI164 in paediatric ASD (July 2022)

    12 July 2022
    View More: Neurotech International (ASX:NTI) – Breakthrough results with NTI164 in paediatric ASD (July 2022)
  • Market Herald – Neurotech International (ASX:NTI) announces “breakthrough” results

    11 July 2022
    View More: Market Herald – Neurotech International (ASX:NTI) announces “breakthrough” results

Footer

Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia

moc.l1749766832anoit1749766832anret1749766832nihce1749766832torue1749766832n@ofn1749766832i1749766832

+61 (8) 9389 3130

Subscribe to our latest announcements

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2025 Neurotech International • Site by White Noise Communications

Download prospectus